Purchase Order 75N95023P00522
Award Date
9/15/23
Potential Completion Date
9/14/24
Potential Value
$105K
Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10019, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $224,000.00 firm fixed price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for the foundation to provide services including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells, and expanding,...
The National Institute of Drug Abuse awarded a $414,000 firm fixed price definitive contract to New York Stem Cell Foundation Inc. to provide expansion, differentiation, and validation of 36 neural progenitor cell lines derived from induced pluripotent stem cells obtained from subjects with psychiatric conditions. The original solicitation sought proposals to outsource these services within specified timeframes, with an emphasis on technical approach. New York Stem Cell Foundation will...
This is a $241,500 firm fixed price contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to the New York Stem Cell Foundation Inc., a non-profit organization. The contract is for the generation and characterization of human induced pluripotent stem cells (iPSCs), neural progenitor cells (NPCs), and stable transgenic iPSC lines from individuals with mood and anxiety disorders. This contract does not have a set-aside...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>
This is a $15,375 firm-fixed-price purchase order contract awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to the New York Stem Cell Foundation, Inc., a non-profit organization. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines from patients with Alzheimer's disease and related dementias, differentiating stem cells into insulin-producing beta cells,...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $206,910.64 firm fixed price delivery order to Medical Science & Computing, LLC. This order was issued against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity multiple award contract vehicle to provide research support services to the Bethesda, Maryland facility. No subcontractors or set...
This $238,000.00 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to the New York Stem Cell Foundation, Inc., a non-profit organization that conducts stem cell research. The contract is for the derivation of induced pluripotent stem cells, which aligns with the foundation's work in generating stem cell lines, differentiating them into various cell types, and...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $46,418 firm fixed price delivery order against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity multiple award contract vehicle. Medical Science & Computing, LLC will serve as the prime contractor providing research support services to further the National Institute on Drug Abuse's mission...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1.46 million firm fixed price delivery order to Medical Science & Computing, LLC. This Task Order #11 was issued against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity master contract vehicle to provide unspecified services in support of NIH programs in Bethesda, Maryland, over a...